(Nasdaq: GILD) will present new clinical and real-world evidence across primary biliary cholangitis (PBC) and chronic ...

AGA and AASLD offer six recommendations for the diagnosis and management of PBC: Use SP100 and GP210 antibodies to help diagnose suspected PBC in those who test negative for antimitochondrial ...

US gastroenterology and liver disease associations issued joint guidelines on diagnosing and treating primary biliary ...

For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for ...

Gilead Sciences, Inc. announced that it will present new clinical and real-world evidence across primary biliary cholangitis (PBC) and chronic hepatitis delta virus (HDV) infection at The Liver ...

For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for ...

Agencies aligned on trial design, endpoints and safety database; FDA agreed NDA-enabling studies can run in parallel with ...

Life science investment firm KD Ventures' portfolio company Umecrine Cognition has received a preliminary patent allowance from the U.S. Patent and Trademark Office, USPTO, for the treatment of ...

PPAR agonists, antigen-specific immune tolerance therapies and IBAT inhibitors lead the PBC pipeline as companies target patients with an inadequate response to UDCA.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

The Russian Ministry of Health has added primary biliary cholangitis, a chronic autoimmune liver disease, to the list of orphan diseases. This is stated in a departmental document, which was reviewed ...

From the world of the infinitely small, an innovative therapeutic strategy to deliver drugs directly to the target. This is the result obtained from a made-in-Italy research that, with nanotechnology, ...

Patients with concurrent PBC and osteoporosis do not have an increased risk of major bone fracture vs patients with ...